1-3 of 3
Nimer Alsaid
Close
Sort by
Journal Articles

Recurrent Venous Thromboembolism (VTE), Major Bleeding (MB), and Associated Cost of Treatment with Low Molecular Weight Heparin (LMWH) or Direct Oral Anticoagulant (DOAC) in High Risk Patients with Gastrointestinal (GI) Malignancies: Retrospective Real-World Analysis at a Comprehensive Cancer Center

Alejandro Recio Boiles, MD, Ali McBride, PharmD,MS, Hani M. Babiker, MD, Nimer Alsaid, PhD MS, PharmD, Ivo Abraham, PhD RN, Emad Elquza, MD MBA
Journal: Blood
Blood (2018) 132 (Supplement 1): 5057.
https://doi.org/10.1182/blood-2018-99-114204
Published: 2018
Journal Articles

Economic Evaluation for the US of Venetoclax Versus Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia with 17p Deletion

Nimer Alsaid, Ali McBride, PharmD,MS, Mok Oh, Daniel Persky, MD, Faiz Anwer, MD, Leslie Andritsos, MD, Abhijeet Kumar, Seongseok Yun, MD PhD, Ivo Abraham, PhD RN
Journal: Blood
Blood (2017) 130 (Supplement 1): 4678.
https://doi.org/10.1182/blood.V130.Suppl_1.4678.4678
Published: 2017
Journal Articles

Economic Evaluation for the US of Ibrutinib Versus Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia with 17p Deletion

Nimer Alsaid, Ali McBride, PharmD,MS, HyunJung Kim, Mok Oh, Leslie Andritsos, MD, Faiz Anwer, MD, Daniel Persky, MD, Abhijeet Kumar, Seongseok Yun, MD PhD, Ivo Abraham, PhD RN
Journal: Blood
Blood (2017) 130 (Supplement 1): 4679.
https://doi.org/10.1182/blood.V130.Suppl_1.4679.4679
Published: 2017